股票 › SYRE
斯派尔治疗 SYRE
美股市值排名 #1451
$103.86 +$7.27 (+7.53%)
休市 · Nov 7, 5:50 am ET · 最新盘后价 $103.00 -0.83%
开盘$98.35
昨收$96.59
当日区间$97.29 – $104.30
成交量1.64M
市值$9.86B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$81.64M-57.2% YoY
净利润-$36.20M+1.4% YoY
摊薄每股收益-$0.43+29.7% YoY
自由现金流-$69.88M-50.1% YoY
经营现金流-$69.88M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-28.5%
资产收益率-20.9%
投入资本回报率-33.2%
流动比率18.53
负债/资产比率6.1%
现金及投资$1.15B
净现金（净负债）$1.15B
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $81.64M | $75.64M | $219.56M | $57.17M | $56.89M |
| 销售及管理费用 | $16.14M | $15.23M | $47.91M | $12.53M | $11.64M |
| -管理费用 | $16.14M | $15.23M | $47.91M | $12.53M | $11.64M |
| 研发费用 | $65.50M | $60.41M | $171.65M | $44.64M | $45.25M |
| 营业利润 | -$81.64M | -$75.64M | -$219.56M | -$57.17M | -$56.89M |
| 非经营性利息净收入（支出） | $10.05M | $7.00M | $24.89M | $7.14M | $5.38M |
| 非经营性利息收入 | $10.05M | $7.00M | $24.89M | $7.14M | $5.38M |
| 其他收入（支出） | $35.39M | -$359,000.00 | $39.46M | -$12.50M | $40.33M |
| 特殊收益（费用） | $40.00M | $30.00M | $10.00M | $0.00 | $0.00 |
| -固定资产出售收益 | $40.00M | $30.00M | $10.00M | $0.00 | $0.00 |
| 其他非经营性收入（支出） | -$4.61M | -$30.36M | $29.46M | -$12.50M | $40.33M |
| 税前利润 | -$36.20M | -$69.01M | -$155.22M | -$62.53M | -$11.18M |
| 税费 | $0.00 | $0.00 | -$15,000.00 | $0.00 | $0.00 |
| 净利润 | -$36.20M | -$69.01M | -$155.20M | -$62.53M | -$11.18M |
| 持续经营利润 | -$36.20M | -$69.01M | -$155.20M | -$62.53M | -$11.18M |
| 归属母公司净利润 | -$36.20M | -$69.01M | -$155.20M | -$62.53M | -$11.18M |
| 归属普通股股东净利润 | -$36.20M | -$69.01M | -$155.20M | -$62.53M | -$11.18M |
| 基本每股收益 | -$0.43 | -$0.74 | -$1.98 | -$0.70 | -$0.18 |
| 摊薄每股收益 | -$0.43 | -$0.74 | -$1.98 | -$0.70 | -$0.18 |
| 报告营业总收入 | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.17B | $763.95M | $777.78M | $777.78M | $504.60M |
| 流动资产合计 | $1.17B | $763.95M | $777.78M | $777.78M | $504.60M |
| 现金及现金等价物与短期投资 | $1.15B | $741.47M | $756.53M | $756.53M | $486.20M |
| -现金及现金等价物 | $162.01M | $97.19M | $85.72M | $85.72M | $64.90M |
| -短期投资 | $983.34M | $644.28M | $670.81M | $670.81M | $421.30M |
| 其他流动资产 | $27.66M | $22.49M | $21.25M | $21.25M | $18.41M |
| 非流动资产合计 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 负债合计 | $71.86M | $93.14M | $62.55M | $62.55M | $49.50M |
| 流动负债合计 | $63.30M | $85.16M | $58.69M | $58.69M | $46.27M |
| 应付款 | $5.77M | $5.74M | $8.92M | $8.92M | $11.43M |
| -应付账款 | $5.72M | $5.69M | $8.90M | $8.90M | $7.46M |
| -一年内应付关联方款项 | $46,000.00 | $50,000.00 | $14,000.00 | $14,000.00 | $3.97M |
| 一年内应计费用 | $20.46M | $24.09M | $18.83M | $18.83M | $18.53M |
| 其他流动负债 | $31.35M | $50.26M | $23.00M | $23.00M | $11.19M |
| 非流动负债合计 | $8.56M | $7.98M | $3.86M | $3.86M | $3.23M |
| 其他非流动负债 | $8.56M | $7.98M | $3.86M | $3.86M | $3.23M |
| 股东权益合计 | $1.10B | $670.81M | $715.24M | $715.24M | $455.10M |
| 股东权益 | $1.10B | $670.81M | $715.24M | $715.24M | $455.10M |
| 股本 | $146.44M | $155.84M | $155.84M | $155.84M | $155.83M |
| -普通股 | $16,000.00 | $15,000.00 | $15,000.00 | $15,000.00 | $13,000.00 |
| -优先股 | $146.43M | $155.82M | $155.82M | $155.82M | $155.82M |
| 资本公积 | $2.19B | $1.71B | $1.69B | $1.69B | $1.36B |
| 留存收益 | -$1.23B | -$1.20B | -$1.13B | -$1.13B | -$1.07B |
| 不影响留存收益的损益 | -$2.40M | -$767,000.00 | $869,000.00 | $869,000.00 | $791,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$69.88M | -$57.37M | -$169.25M | -$44.58M | -$37.12M |
| 持续经营经营活动现金流净额 | -$69.88M | -$57.37M | -$169.25M | -$44.58M | -$37.12M |
| 持续经营净利润 | -$36.20M | -$69.01M | -$155.20M | -$62.53M | -$11.18M |
| 持续经营损益 | -$40.00M | -$30.00M | -$10.00M | $0.00 | $0.00 |
| 其他非现金项目 | $5.29M | $30.27M | -$29.77M | $12.43M | -$42.16M |
| 营运资金变动 | -$9.01M | $244,000.00 | -$5.93M | -$2.27M | $5.94M |
| -预付资产变动 | -$5.61M | -$233,000.00 | -$12.82M | -$2.88M | -$6.16M |
| -应付账款及应计费用变动 | -$3.40M | $477,000.00 | $6.89M | $615,000.00 | $12.10M |
| 投资活动现金流净额 | -$297.90M | $56.58M | -$143.48M | -$247.41M | $25.00M |
| 持续经营投资活动现金流净额 | -$297.90M | $56.58M | -$143.48M | -$247.41M | $25.00M |
| 无形资产购置及出售净额 | $40.00M | $30.00M | $7.00M | $0.00 | $0.00 |
| 投资购置及出售净额 | -$337.90M | $26.58M | -$150.48M | -$247.41M | $25.00M |
| 筹资活动现金流 | $432.60M | $12.26M | $309.03M | $312.81M | -$4.64M |
| 持续经营筹资活动现金流净额 | $432.60M | $12.26M | $309.03M | $312.81M | -$4.64M |
| 普通股发行净额 | $435.24M | $9.75M | $311.13M | $311.13M | $0.00 |
| 股票期权行使所得 | $20.58M | $2.68M | $3.31M | $1.75M | $608,000.00 |
| 其他筹资费用净额 | -$23.22M | -$171,000.00 | -$5.41M | -$69,000.00 | -$5.25M |
| 期末现金余额 | $162.01M | $97.19M | $85.72M | $85.72M | $64.90M |
| 现金净变动 | $64.82M | $11.46M | -$3.70M | $20.82M | -$16.76M |
| 期初现金余额 | $97.19M | $85.72M | $89.42M | $64.90M | $81.66M |
| 自由现金流 | -$69.88M | -$57.37M | -$169.25M | -$44.58M | -$37.12M |
| 折旧、折耗与摊销 | – | – | $0.00 | – | – |
| -应收款变动 | – | – | $0.00 | – | – |
| -其他流动负债变动 | – | – | $0.00 | – | – |
| 固定资产购置及出售净额 | – | – | $0.00 | – | – |
| 业务购买及出售净额 | – | – | $0.00 | – | – |
| 优先股发行净额 | – | – | $0.00 | $0.00 | – |
| 汇率变动影响 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 SYRE。
登录后参与讨论。